1,572 reports of this reaction
1.4% of all COPPER reports
#17 most reported adverse reaction
VAGINAL HAEMORRHAGE is the #17 most commonly reported adverse reaction for COPPER, manufactured by CooperSurgical, Inc.. There are 1,572 FDA adverse event reports linking COPPER to VAGINAL HAEMORRHAGE. This represents approximately 1.4% of all 116,047 adverse event reports for this drug.
Patients taking COPPER who experience vaginal haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VAGINAL HAEMORRHAGE is a less commonly reported adverse event for COPPER, but still significant enough to appear in the safety profile.
In addition to vaginal haemorrhage, the following adverse reactions have been reported for COPPER:
The following drugs have also been linked to vaginal haemorrhage in FDA adverse event reports:
VAGINAL HAEMORRHAGE has been reported as an adverse event in 1,572 FDA reports for COPPER. This does not prove causation, but indicates an association observed in post-market surveillance data.
VAGINAL HAEMORRHAGE accounts for approximately 1.4% of all adverse event reports for COPPER, making it a notable side effect.
If you experience vaginal haemorrhage while taking COPPER, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.